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Abstract
Background: Homeless and marginally housed persons who use alcohol and/or illicit drugs often have end-of-life
care needs that go unmet due to barriers that they face to accessing end-of-life care services. Many homeless and
marginally housed persons who use these substances must therefore rely upon alternate sources of end-of-life care
and support. This article explores the role of harm reduction services in end-of-life care services delivery to
homeless and marginally housed persons who use alcohol and/or illicit drugs.
Methods: A qualitative case study design was used to explore end-of-life care services delivery to homeless and
marginally housed persons in six Canadian cities. A key objective was to explore the role of harm reduction services.
54 health and social services professionals participated in semi-structured qualitative interviews. All participants
reported that they provided care and support to this population at end-of-life.
Results: Harm reduction services (e.g., syringe exchange programs, managed alcohol programs, etc.) were identified
as a critical point-of-entry to and source of end-of-life care and support for homeless and marginally housed
persons who use alcohol and/or illicit drugs. Where possible, harm reduction services facilitated referrals to
end-of-life care services for this population. Harm reduction services also provided end-of-life care and support
when members of this population were unable or unwilling to access end-of-life care services, thereby improving
quality-of-life and increasing self-determination regarding place-of-death.
Conclusions: While partnerships between harm reduction programs and end-of-life care services are identified as
one way to improve access, it is noted that more comprehensive harm reduction services might be needed in
end-of-life care settings if they are to engage this underserved population.
Background
At any given moment, tens of thousands of people in
Canada are homeless or marginally housed [1,2]—that is,
live places unfit for human habitation (e.g., outdoors,
vehicles, etc.) or temporary, transitional, or emergency
accommodations (e.g., emergency shelters, hostels, etc.).
Homeless and marginally housed persons have consist-
ently reported levels of alcohol and/or illicit drug use
many times higher than the stably housed population
[3-7]. For example, a recent study of a large sample of
homeless persons in Toronto found that 60% had a life-
time prevalence of regular illicit drug use and 40%
reported active use of illicit drugs other than marijuana
[3]. A cohort study of homeless and marginally housed
youth in Vancouver reported that 41.1% had used drugs
by injection [4]. Another study of homeless women in
Vancouver noted that 82.4% of its sample regularly used
substances, including illicit drugs (70.5%) and alcohol
(37.8%) [5].
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lated with a range of adverse health outcomes [8-10], in-
cluding high levels of morbidity and mortality [11-13], that
are frequently exacerbated by substance use. Injection
drug use and non-injection use of crack cocaine and crys-
tal methamphetamine are risk factors for HIV and Hepa-
titis C (HCV) infection [14-18], resulting in high infection
rates among homeless and marginally housed persons who
use these substances [18-20]. Furthermore, injection drug
use and non-injection use of crack cocaine and crystal
methamphetamine have been shown to accelerate HIV
and HCV disease progression, leading to higher incidences
of cirrhosis, hepatocellular carcinoma, opportunistic infec-
tions, and AIDS-related cancers among these populations
[21-24]. Heavy alcohol consumption is similarly linked to
HIV and HCV disease progression, resulting in similarly
poor outcomes [25-27]. Homeless and marginally housed
populations consequently suffer from high mortality rates
and life expectancies at least a decade less than those of
the general population [11-13].
Homeless and unstably housed persons who use alcohol
and/or illicit drugs have complex end-of-life care needs,
which are compounded by the challenges of everyday
survival (i.e., securing food and shelter) [28-31]. In spite of a
high level of need, this population faces many barriers
to accessing the end-of-life care system [28,32]. While
many populations in Canada report difficulties accessing
end-of-life care services (e.g., Aboriginal peoples and people
living in rural areas [33-35]), the realities of homelessness
and drug and/or alcohol use pose particular challenges.
End-of-life care services have been largely developed based
on assumptions (i.e. individuals are housed, supported by
family and friends, and/or have resources to pay for supple-
mentary care) that do not reflect the experience of this
population. Homeless and marginally housed persons who
use alcohol and/or illicit drugs lack access to end-of-life care
services where these services are delivered via home care or
pay-for-service facilities. Furthermore, end-of-life care ser-
vices providers often enforce rules and regulations (e.g.
anti-drug policies) that exclude this population from acces-
sing care [32]. Although several low-threshold hospices
have implemented harm reduction policies (i.e.: permitting
onsite prescribed alcohol use, providing injecting equipment
and permitting off-site illicit drug use), this end-of-life care
service delivery model has not been widely implemented.
Many homeless and marginally housed persons who
use drugs and/or alcohol presumably rely on alternate
sources of care and support at end-of-life. While
researchers have increasingly turned their attention
toward the end-of-life care needs of this population
[28-32], they have not explored alternate sources of
end-of-life care and support for this population. For ex-
ample, what services do homeless and unstably housed
persons who use alcohol and/or illicit drugs turn to for
end-of-life care and support? What level of support and
care are these services able to provide? And also, what
role do these services play in facilitating access to more
comprehensive end-of-life care?
In Canada, as in many other countries, harm reduction
programming is a central component of public health
strategies. Harm reduction emphasizes interventions that
minimize the drug and health harms associated with al-
cohol and/or drug use (e.g., overdose, infectious diseases,
etc.) while not requiring abstinence as a condition for
accessing services [36]. A growing body of research has
noted that harm reduction services are one of the princi-
pal and often only sources of medical care and referrals
for homeless and marginally housed persons who use al-
cohol and/or illicit drugs in Canada [37-42]. However,
this research has overlooked any role that these pro-
grams play in facilitating access to end-of-life care and
support for this population. This article explores how
harm reduction services act as a point-of-entry to and
source of end-of-life care and support for this population
based on qualitative interviews with key informants in
six Canadian cities. Although data collection was limited
to a country with universal healthcare insurance, findings
from this study provide insights that are likely applicable
to other jurisdictions where harm reduction programs
are involved in the delivery of health and social services
to homeless and marginally housed persons.
Methods
Study design
We used a qualitative case study design to explore end-of-
life care services delivery to homeless and unstably housed
persons with problematic use of alcohol and/or illicit
drugs [43], with an emphasis on points-of-entry to and
sources of end-of-life care and support. We conducted
qualitative interviews with health and social services pro-
fessionals (e.g., emergency shelter directors, physicians,
nurses, etc.) between February 2007 and August 2008 in
which we explored this topic. Given the lack of previous
research in this area, qualitative interviews were deemed
to be the best means through which to generate prelimin-
ary insights into factors that shape sources of end-of-life
care for this population. We originally intended to also
conduct interviews with homeless and unstably housed
persons who use alcohol and/or illicit drugs that had been
diagnosed as being terminally ill at the primary site of this
study (i.e., Ottawa), but determined this was not feasible
after conducting preliminary interviews with these partici-
pants (n=5). We ultimately decided that we could not
guarantee that the data would be of sufficient quality due
to poor recall of events and inconsistency in the reporting
of these events. We were also concerned that many parti-
cipants would be unable to provide informed consent due
to cognitive deficits (e.g., HIV-related dementia, impaired
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would place an undue burden on participants with a high
severity of illness. In spite of this limitation, we felt that
interviews with key informants (i.e., health and social ser-
vices professions who provide end-of-life care and support
to homeless populations) would allow us to generate the
best possible insights into the needs of this population.
Participants & recruitment
Key informants involved in the delivery of health and
end-of-life care services to homeless and unstably housed
persons in Halifax, Ottawa, Hamilton, Toronto, Thunder
Bay, and Winnipeg were invited to participate in this study.
An advisory committee made up of regional experts (i.e., se-
nior health and social services professionals who provide
services to homeless persons), as well as existing relation-
ships with homeless services organizations in Ottawa and
Toronto, helped us to identify key informants in those cit-
ies. Key informants in Halifax, Hamilton, Thunder Bay, and
Winnipeg were identified through a scoping review of
health services for homeless persons in those cities.
Seventy-three potential participants were sent a letter or
email by the lead author providing an overview of the study
and inviting them to participate. Fifty-four individuals (74%)
agreed to participate in this study, including physicians (6),
nurse practitioners (2), nurses (16), social workers (5),
emergency shelter or supportive housing executive directors
and/or senior managers (9), harm reduction specialists (5),
outreach workers (7), and personal support workers (4).
Many participants worked in harm reduction-based set-
tings, such as low-threshold hospices (15), managed alcohol
programs (8), and syringe and/or safer crack use kit distri-
bution programs (8), and the remainder of participants
reported regular contact with these services.
Data collection
Semi-structured interviews were conducted with partici-
pants at their place of employment or an alternate loca-
tion of their choosing. Participants were asked to discuss
a range of topics related to end-of-life care services deliv-
ery to homeless and marginally housed persons who use
alcohol and/or illicit drugs, including points-of-entry and
sources of end-of-life care and support. Interviews ran-
ged in length from 45 to 120 minutes, although the ma-
jority of interviews were approximately one hour in
length. Interviews were audio recorded with the consent
of participants and transcribed verbatim by research
assistants. Each transcript was reviewed by the lead au-
thor while listening to the audio file to verify the accur-
acy of the transcript and make any necessary corrections.
Data analysis
The goal of analysis for this article was to explore how
homeless persons who use alcohol and/or illicit drugs
gain access to end-o-life care services, as well as non-
traditional sources of end-of-life care and support. Tran-
scripts were imported into qualitative analysis software
(NVivo v.8) to facilitate coding [44]. A preliminary set of
two categories extracted from the interview guide (e.g.
points-of-entry to end-of-life care services and sources
of end-of-life care and support) was used to provide an
initial framework for the analysis. We concurrently
coded the transcripts by drawing upon constant com-
parative methods, whereby emerging sub-categories
were recorded and explicated by means of constant com-
parison to the data [45,46]. We determined early in
analysis that harm reduction services served as a key
point-of-entry and source of end-of-life care and support
for homeless and marginally housed persons who use al-
cohol and/or illicit drugs. We adjusted the coding frame-
work to account for the outreach (i.e. drop-in and
outreach syringe exchange and distribution) and residen-
tial programs (i.e., services, such as managed alcohol
programs and low threshold emergency shelters, where
clients are permitted to be intoxicated or actively use)
available in these cities. We discussed and further revised
the coding framework during subsequent meetings until
the final themes and sub-themes were established. Once
these final categories were established, the lead author
independently recoded sections of the data to verify the
validity of these categories.
Ethics
This study received approval from the institutional re-
search ethics committees at Saint Paul University and
the University of British Columbia. Informed consent
was obtained prior to the interviews and participants
retained a duplicate copy of the informed consent proto-
col for their records. In order to maintain participant
anonymity and confidentiality, where participants are
quoted directly, they are identified by their professional
role.
Results
Participants identified many barriers to end-of-life care
services for homeless and marginally housed persons
who use alcohol and/or illicit drugs, which are reviewed
in-depth elsewhere [32]. This article focuses instead on
the role harm reduction services play in addressing gaps
in end-of-life care services by providing care and support
for homeless and marginally housed persons who use al-
cohol and/or illicit drugs. Eight themes are grouped into
three domains to shed light on this dynamic: first, how
harm reduction programs act as a point-of-entry to
end-of-life care services; second, how harm reduction
outreach programs serve as a source of end-of-life sup-
port; and, finally, how residential harm reduction pro-
grams serve as a source of end-of-life care and support.
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Harm reduction services as a point-of-entry to end-of-life
care services
Increasing engagement with population
Participants reported that, while multiple social and
structural barriers restricted access to end-of-life care
services for homeless and marginally housed persons
who use alcohol and/or illicit drugs (e.g. lack of afford-
ability, abstinence-only policies, etc.), one of the principal
barriers was an overall lack of engagement with health
and social care services. They noted that delivering ser-
vices via harm reduction programs helped them to estab-
lish contact and build trusting relationships with this
population. Participants felt that, by using a non-judg-
mental harm reduction approach, they were able to bet-
ter engage with this population. As one participant
noted:
You have to earn it. You have to show that you want
to do something for them. I’m going to make sure that
it gets done and that it’s followed up. You have to be
respectful and treat people with the same kind of
treatment that you would want. I’m often very
informal. I use humour but, most of all, I think that
you earn it. It's often word of mouth. One client will
say, “Listen, you can trust her." (Harm Reduction
Outreach Worker)
Individuals come in through the needle exchange
program and they come in and talk. Over time, you
build a sense of confidence and then become more
conversational about what’s happening and what their
needs are. It takes time for people to be willing to
trust or to think it is worthwhile to trust. (Harm
Reduction Outreach Worker)
Participants strongly felt that these relationships
allowed them to better facilitate referrals to end-of-life
care services for this population. Several physicians
acknowledged the critical role that harm reduction ser-
vices played in facilitating access to end-of-life care ser-
vices for this population. For example:
It’s the outreach worker that will do the vast majority
of the work. It’s thanks to these guys that I’m able to
see the clients. The client has trust with the team and
then I become a part of the team so they’re able to
trust me. (Physician)
Engaging with clients over time
Participants reported that, since many homeless and mar-
ginally housed persons who use alcohol and/or illicit drugs
regularly accessed harm reduction services, they were able
to maintain frequent contact with this population. Partici-
pants articulated how this long-term engagement mediated
access to end-of-life care services. Many participants noted
that, because harm reduction programs provided ongoing
and often the only care and support for this population,
they were positioned to monitor changes in health status.
Consequently, they were positioned to facilitate referrals to
end-of-life care services when necessary. For example:
We have a lot of the guys that been here [harm
reduction program] for six years now. They’re all
getting older and you can tell that the alcohol is
hitting them harder. At one point, their health needs
are just too much just for us but there’s nowhere for
them to go unless they’re really actually sick and can
go to the end-of-life care provider. (Nurse)
He’s there every day. He’s getting sicker. He’s not
housed. Three or four of these clients since I’ve
started working here have been recognized by the
workers at [harm reduction program]. They know to
call us and that we’ll follow through with helping with
appointments and referrals to the [end-of-life care
provider]. (Nurse)
Maintaining relationships with end-of-life care providers
Participants felt that it was important for harm reduction
programs and end-of-life care providers to maintain rela-
tionships to facilitate access to end-of-life care services
for homeless and marginally housed persons who use al-
cohol and/or illicit drugs. Many participants who worked
for harm reduction programs indicated that they sought
out opportunities to formally link with end-of-life care
providers in their communities. These participants
believed that these links with end-of-life care providers
not only served to facilitate referrals, but also allowed
them to generally advocate for end-of-life care services
for this population. One participant remarked:
We are now part of a community palliative care
committee. That committee looks at the services that
are available and what’s needed—the gaps that exist
for homeless and under-housed in terms of end-of-life
care. We might recognize that someone is very ill so it
is a matter of getting them to a physician and then
making an application to move them into a palliative
care facility. (Nurse)
Many participants who worked in end-of-life care set-
tings also acknowledged the importance of these links.
These participants reported that links with harm reduc-
tion programs helped them gain access to a population
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life care to. For example:
People who are living on the street...it’s much harder
to access them. They don’t come to us and they don’t
go anywhere for help until they’re so sick that they’re
picked up by an ambulance. I’ll get calls from street
nurses. Somebody will say, "I’ve got somebody that I
think is going to need to come to you at some point.”
(Hospice Administrator)
Harm reduction outreach services as a source of
end-of-life care
Providing end-of-life support to clients unable to access
services
Participants reported that harm reduction outreach pro-
grams were often one of the only sources of end-of-life sup-
port available to this population. Participants acknowledged
that, while these programs lacked the resources to provide
end-of-life care (e.g. pain and symptom management, coun-
s e l l i n g ,e t c . ) ,t h e yw e r ea b l et op r o v i d ear a n g eo fs u p p o r t
services via these programs. Many of these support services
(e.g. personal support, housing assistance, etc.) were
intended to help homeless and marginally housed persons
who use alcohol and/or illicit drugs meet their most basic
needs (e.g. shelter, food, etc.) at end-of-life and thereby
minimize to the greatest extent possible the hardships asso-
ciated with poverty and homelessness. For example:
We had one fellow that died but he had no place to
live. He wasn’t welcome at the local shelter because of
some of his behaviours. He was sitting out there in his
wheelchair on the corner ready to take on all comers
and the police brought him to our office. A co-worker
had a big office that had a couch in it and the police
would bring him in with a bag of McDonalds. He
would lie on the couch for the day. At the end of the
day, we all had homes to go to and we couldn’t let
him stay there. We would find a place and sometimes
we would find someone willing to put him in a hotel
overnight. It would be four-thirty on a Friday
afternoon and I would be searching and scrounging
and finally find one loophole and get him some place
for the weekend. (Harm Reduction Outreach Worker)
Participants reported that unstably housed persons (e.
g. living in single room occupancy hotels or apartments
not fit for human habitation) with substance use chal-
lenges also received end-of-life support via harm reduc-
tion outreach programs. They noted that they provided
end-of-life support services (e.g.: personal care, emo-
tional support, etc.) to this population as part of or in
addition to the regular outreach services. Participants
identified several reasons why this population received
end-of-life support from these programs, such as poor
access to home care services and comfort with harm re-
duction outreach workers. As one participant noted:
We had a few clients that were old time clients that
were HIV-positive and turned into AIDS. There was a
place down on the South end where a lot of the addicts
live. We had support staff that would go down and help
with this person. We’ll make home visits because they
feel more comfortable with us because they’ve been
with us for so long. (Harm Outreach Worker)
When I first started working here, there was a client
who was dying of AIDS and [an outreach worker]
used to go down every day and of sit with him for a
while... There was another guy dying from hepatitis C
complications—liver cirrhosis—and [the outreach
worker] would go sit with him, talk to him, help him
out, you know. Clean him and wash him, things like
that. (Harm reduction outreach worker)
Providing end-of-life support to clients who wish to ‘die at
home’
Participants indicated that, when end-of-life care services
were available, some unstably housed persons who used
substances refused referrals to end-of-life care providers,
preferring instead to die-at-home (e.g. single room occu-
pancy hotels or apartments not fit for human habitation).
Participants reported that such persons indicated to
them that the benefits of end-of-life care services (i.e.,
supportive care, pain and symptom management, etc.)
were outweighed by the drawbacks, notably disruptions
in living environment (e.g. peer support networks, etc.)
and lack of self-determination of place-of-death. Partici-
pants who worked at harm reduction outreach programs
expressed that they were committed to supporting cli-
ents who wished to die at home. As a result, they
reported that they provided and facilitated a range of
end-of-life support services for this population that were
outside of the scope of their everyday responsibilities.
For example:
We had one fellow that was an injection drug user. He
was HIV-positive for many years and continuously
used and drank. He was in and out of hospital. He got
to the point where he knew he was dying and he
wanted to die with his [single room occupancy hotel]
friends. We were able to work around that. We had
nurses from here going in. We had doctors going in. It
was home until he finally did die. (Harm reduction
outreach worker)
There was an individual I’d worked with for a number
of years...He lived [in an apartment in the west end]
McNeil et al. BMC Public Health 2012, 12:312 Page 5 of 9
http://www.biomedcentral.com/1471-2458/12/312and he died of Hepatitis C and HIV there. I would go
over and see him and we’d talk and I’d smudge him [i.
e. perform an Aboriginal purification ceremony]. It
was just a matter of being there for him on a daily
basis. (Harm reduction outreach worker)
Residential harm reduction programs as a source of end-
of-life care
Providing culturally-competent care
Participants reported that residential harm reduction pro-
grams (i.e. managed alcohol programs and low barrier
emergency shelters) served as a key source of end-of-life
care services for homeless persons who use substances at
end-of-life. Many participants noted that the delivery of
end-of-life care services in these settings was an extension
of the range of other clinical and support services delivered
onsite (e.g. medication assistance, nursing care, etc.) and
responded to the natural progression of health needs
experienced by their clients (e.g. HCV, HIV/AIDS, etc.).
Participants acknowledged that, while unable to provide
services equal to those provided in end-of-life care set-
tings, they had greater cultural competence in providing
care for this population. Participants strongly felt that they
were better able to provide care that responded to the
unique needs of this population and acknowledged their
lived experiences. As one participant observed:
Staff members are not trained in palliative care but
they have many years of experience working with
people with heavy substance use, heavy alcohol use,
difficult behaviours and mental health problems. This
is the group that they’ve chosen to work with. It’s not
like five percent of the people that they work with. It’s
everybody they work with. (Physician)
Providing end-of-life care for clients in a home setting
Participants acknowledged that many clients identified
residential harm reduction programs as home and
expressed a strong desire to die there. One of the key
reasons for this was that many clients of these programs
had been long-term residents of these programs and
established strong relationships with other residents and
staff. Many of the participants in this study articulated
how strong relationships with residents motivated them
to support these clients at end-of-life. For example:
The guys know that we’ll keep them here as long as
possible and that we’ll try to increase nursing hours.
We’ll try to do anything to keep them here because
they are family. It’s like they want to die in their home.
(Nurse)
We would discuss their wishes in terms of where they
would like to spend their last weeks or months and
their options would basically fall into two categories.
It would be either arranging something at the hospital
or spending their last bit of time in this program.
Certainly, we wouldn’t be able to provide the same
level of care that they might receive in the hospital but
we might still be more desirable—passing away at
home because the program environment had indeed
become their home and their community. (Physician)
Implications of end-of-life care and support for regular
services
Participants acknowledged that delivering end-of-life
care services via residential harm reduction programs
impacted the delivery of regular services to program cli-
ents. One of the key implications noted by participants
was that they had to divert limited resources to provid-
ing end-of-life care to clients. Several participants
reported that in spite of their best intentions it became
necessary to refer some of these clients to end-of-life
care settings when it became clear that they would be-
come overextended. One participant noted:
It got to the point with cirrhosis of the liver that he
had problems going to the bathroom. He couldn’t
sleep on the overnight and was afraid to sleep because
he thought he was not going to wake up. Staff
members had to basically spend twenty four hours
with this individual. That is when we realized we had
nine other residents. Staff members were saying that
we really want to support this client but it’s impossible
for us. At that point, we said,‘Okay, we really need to
make a referral.’ (Harm reduction specialist)
Many participants also articulated how they learned from
these experiences in order to be better equipped to provide
care to subsequent clients who were dying. For example:
We kind of got caught off guard because our first
client that got sick was quite young and experienced
profound liver failure, extremely fast. He had to go to
the hospital. He didn’t want to but he had to. We
didn’t have any nursing support in place. We didn’t
have equipment. We didn’t have the drugs. He had to
go to the hospital to die. It set us into our planning
stage for the next event—getting equipment, nurses,
drugs, and all these things in place for the next
person. (Nurse Manager)
Discussion
Over the course of this study, participants articulated how
harm reduction services act as an alternate source of end-
of-life care and support for homeless and marginally
housed persons who use alcohol and/or illicit drugs. Parti-
cipants highlighted how establishing trusting relationships
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end-of-life care services. Previous research has similarly
noted that harm reduction services (e.g. syringe exchange
programs, supervised injection facilities, etc.) are key
points-of-referral to health care services for substance-
using populations [37-42], but only recently has attention
turned to the health care interactions that facilitate these
referrals [47-49]. For example, in a recent study of client
perspectives of a syringe exchange program in a mid-sized
Canadian city, MacNeil and Pauly [47] noted that adopting
a non-judgmental approach led to the trusting relation-
ships between clients and staff as well as linkages to other
healthcare services. While the findings presented in this
article further outline the importance of trust in mediating
access to healthcare services—in this case, end-of-life care
services, closer scrutiny of the characteristics of these rela-
tionships is needed to identify how they improve engage-
ment with this population.
Participants also identified harm reduction programs as
an alternate and often the only source of end-of-life care
and support available to homeless and marginally housed
persons who use alcohol and/or illicit drugs. For example,
participants reported that harm reduction outreach pro-
grams provided a range of end-of-life support services
(e.g. personal support, housing assistance, etc.) for un-
stably housed persons who were unable or unwilling
to access end-of-life care services as a result of social and
structural barriers to these services. While participants
felt that they improved clients’ quality of life by providing
these basic support services, they acknowledged that
they could not provide care equal to that provided in
end-of-life care settings. In light of these limitations,
there remains a need to develop interventions that
minimize to the greatest extent possible barriers this
population faces to end-of-life care services. Fostering
partnerships between harm reduction outreach programs
and end-of-life care teams is one approach that might im-
prove access to end-of-life care for this population
[50,51]. Harding et al. [51] have previously noted that
partnerships between community health programs (in-
cluding substance use programs) and end-of-life
care teams are critical to enhancing access and equity in
end-of-life care services for underserved populations.
Our findings also suggest that homeless or unstably
housed persons who use substances might refuse refer-
rals to end-of-life care services because they wish to die
at “home” (i.e., residential harm reduction programs, sin-
gle room occupancy hotels, or apartments unfit for
human habitation) supported by harm reduction out-
reach workers. Participants pointed out that they pro-
vided end-of-life care and support for this population
because they were motivated to support clients who
wished to die at home (or had no alternative). Although
researchers have increasingly explored the end-of-life
care needs of this population (28-32), they have largely
overlooked any concerns related to place-of-death for
homeless and unstably housed persons, in general, and
homeless and marginally housed persons who use alco-
hol and/or illicit drugs, in particular. Our findings sug-
gest that many homeless and marginally housed persons
who use alcohol and/or illicit drugs might wish to die-at-
home for many of the same reasons their stably housed
counterparts wish to (e.g. comfort, familiarity, presence
of loved ones, etc.) [52]. And yet, precisely because this
population typically lacks reliable caregivers and/or
home-based end-of-life care services, they run the risk of
dying alone, anonymously, and with unmet care needs.
While harm reduction programs play a vital role in min-
imizing these adverse outcomes, action is clearly needed
to address multiple social and structural inequities (e.g.
availability of affordable housing, home care services,
etc.) that constrain the ability of this population to exer-
cise agency in regards to place of death.
Finally, our findings echo those of previous studies
reporting that harm reduction programs serve as an al-
ternate healthcare delivery system for homeless persons
who use substances [53,54]. Some of the main advan-
tages of delivering healthcare services via harm reduction
programs include increased responsiveness to the popu-
lation’s needs and flexibility, as well as promoting dignity
and respect for persons who use substances [53,54].
However, while alternate healthcare services delivery via
harm reduction programs improves access for homeless
and marginally housed persons who use alcohol and/or
illicit drugs, it also leads to separate but not equal
healthcare services for this population [54]. In light of
this concern, more comprehensive strategies in addition
to those outlined above are needed to reduce or elimin-
ate the barriers that substance-using populations face to
accessing end-of-life care services.
Integrating more comprehensive harm reduction
approaches (e.g. supervised drug consumption services)
into end-of-life care services represents one way to
potentially improve access and equity in end-of-life care
services for this population [32]. A growing body of
research suggests that supervised drug consumption ser-
vices are an effective strategy for increasing health access
[55,56], minimizing accidental overdoses [55,57,58], and
encouraging safer drug use practices [59,60] among illicit
drug users. Further research is needed to determine
whether these and other benefits extend to other health-
care settings adopting this approach. Partnering organi-
zations with expertise providing these services with the
end-of-life care system is worth exploring to facilitate
their expansion into end-of-life care settings.
We acknowledge that harm reduction programs have
faced community opposition [61-63], which might re-
strict their integration into these settings, yet several
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theless successfully implemented harm reduction
approaches. For example, the Dr. Peter Centre, a com-
munity-based health facility in Vancouver, Canada that
provides clinical and support services to persons living
with HIV/AIDS including end-of-life care, has integrated
supervised injection services into its programming since
2002. An evaluation of the impact of comprehensive
harm reduction services in these settings might yield fur-
ther insights into how harm reduction programming
might be integrated into end-of-life care.
Limitations
This study has several limitations that should be noted.
Our findings have limited generalizability to regions
where health care services are organized differently (e.g.
lack of universal health insurance) and/or drug policy
prohibits harm reduction services or limits their role in
health care services delivery to this population. While
this articles draws on interviews with a range of experi-
enced health and social care professionals who work with
homeless and marginally housed persons who use alco-
hol and/or illicit drugs, it does not report on the first
hand experiences of this population. Additional research
is needed to explore the specific concerns and experi-
ences of this population. Finally, this qualitative study
was exploratory in nature. The insights generated will
help to inform further research.
Conclusion
In Canada, as elsewhere [28], the end-of-life care system
is largely inaccessible to homeless and marginally housed
persons who use alcohol and/or illicit drugs. This study
explored how harm reduction programs (e.g., syringe ex-
change programs, managed alcohol programs, etc.) have
emerged as an important point-of-referral to and vital al-
ternate source of end-of-life care for this population. Im-
portantly, harm reduction programs were perceived as a
means to provide culturally-competent care and increase
self-determination regarding place-of-death. Notwith-
standing the benefits of this approach, action is clearly
needed to increase access and equity in the end-of-life
care system for this population. This study identified sev-
eral ways that this may be achieved, namely increased
collaboration between the public health and end-of-life
care systems and adoption of harm reduction approaches
in end-of-life care settings.
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